Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
2012 | A Knock-In Npm1 Mutation in Mice Results in Myeloproliferation and Implies a Perturbation in Hematopoietic Microenvironment | Chou S.-H.; BOR-SHENG KO ; Chiou J.-S.; Hsu Y.-C.; MONG-HSUN TSAI ; Chiu Y.-C.; Yu I.-S.; SHU-WHA LIN ; HSIN-AN HOU ; Kuo Y.-Y.; Lin H.-M.; Wu M.-F.; WEN-CHIEN CHOU ; HWEI-FANG TIEN | PLoS ONE | 20 | 17 | |
2020 | Knock-out of Hopx disrupts stemness and quiescence of hematopoietic stem cells in mice | CHIEN-CHIN LIN ; CHI-YUAN YAO ; Hsu, Yueh-Chwen; HSIN-AN HOU ; CHANG-TSU YUAN ; Li, Yi-Hung; Kao, Chein-Jun; Chuang, Po-Han; Chiu, Yu-Chiao; Chen, Yidong; WEN-CHIEN CHOU ; HWEI-FANG TIEN | Oncogene | 14 | 12 | |
2023 | Lineage switch of KMT2A-rearranged adult B-lineage acute lymphoblastic leukemia following bispecific T-cell engager and monoclonal antibody therapy | Wu, Jia-Rong; Shih, Pei-Chun; Li, Ching; Chao, Hsiao-Ling; Wang, Hsiao-Chun; Chiang, Yi-Mei; Liu, Yu-Jung; SZU-CHUN HSU ; CHI-YUAN YAO ; Chen, Lo-Ho; CHIEN-CHIN LIN ; HWEI-FANG TIEN ; WEN-CHIEN CHOU | JOURNAL OF HEMATOPATHOLOGY | 0 | 0 | |
2019 | Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome | HUAI-HSUAN HUANG ; Chen F.-Y.; WEN-CHIEN CHOU ; HSIN-AN HOU ; BOR-SHENG KO ; Lin C.-T.; JIH-LUH TANG ; Li C.-C.; MING YAO ; WOEI TSAY ; SZU-CHUN HSU ; SHANG-JU WU ; Chen, Chien-Yuan ; SHANG-YI HUANG ; Tseng M.-H.; HWEI-FANG TIEN ; Chen R.-H. | BMC Cancer | 41 | 34 | |
2007 | Marrow angiogenesis-associated factors as prognostic biomarkers in patients with acute myelogenous leukaemia | Lee C.-Y.; HWEI-FANG TIEN ; CHUNG-YI HU ; WEN-CHIEN CHOU ; LIANG-IN LIN | British Journal of Cancer | 44 | 35 | |
2008 | Marrow osteopontin level as a prognostic factor in acute myeloid leukaemia | Lee C.-Y.; HWEI-FANG TIEN ; HSIN-AN HOU ; WEN-CHIEN CHOU ; LIANG-IN LIN | British Journal of Haematology | 16 | 14 | |
2018 | Mayo Alliance Prognostic Model for Myelodysplastic Syndromes: Integration of Genetic and Clinical Information | Tefferi A.; Gangat N.; Mudireddy M.; Lasho T.L.; Finke C.; Begna K.H.; Elliott M.A.; Al-Kali A.; Litzow M.R.; Hook C.C.; Wolanskyj A.P.; Hogan W.J.; Patnaik M.M.; Pardanani A.; Zblewski D.L.; He R.; Viswanatha D.; Hanson C.A.; Ketterling R.P.; JIH-LUH TANG ; WEN-CHIEN CHOU ; CHIEN-CHIN LIN ; CHENG-HONG TSAI ; HWEI-FANG TIEN ; HSIN-AN HOU | Mayo Clinic Proceedings | 18 | 19 | |
2015 | An mRNA expression signature for prognostication in de novo acute myeloid leukemia patients with normal karyotype | MING-KAI CHUANG ; Chiu Y.-C.; WEN-CHIEN CHOU ; HSIN-AN HOU ; Tseng M.-H.; Kuo Y.-Y.; Chen Y.; Chuang E.Y.; HWEI-FANG TIEN | Oncotarget | 37 | 40 | |
2012 | Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia | Kantarjian H.M.; Thomas X.G.; Dmoszynska A.; Wierzbowska A.; Mazur G.; Mayer J.; Gau J.-P.; WEN-CHIEN CHOU ; Buckstein R.; Cermak J.; Kuo C.-Y.; Oriol A.; Ravandi F.; Faderl S.; Delaunay J.; Lys?k D.; Minden M.; Arthur C. | Journal of Clinical Oncology | 940 | 857 | |
2014 | The N-terminal CEBPA mutant in acute myeloid leukemia impairs CXCR4 expression | YUAN-YEH KUO ; HSIN-AN HOU ; YIN-KAI CHEN ; Li, Li-Yu; Chen, Po-Hsuen; Tseng, Mei-Hsuan; Huang, Chi-Fei; Lee, Fen-Yu; Liu, Ming-Chih; Liu, Chia-Wen; WEN-CHIEN CHOU ; Liu, Chieh-Yu; JIH-LUH TANG ; MING YAO ; HWEI-FANG TIEN | Haematologica | 10 | 10 | |
2006 | A novel fluorescence-based multiplex PCR assay for rapid simultaneous detection of CEBPA mutations and NPM mutations in patients with acute myeloid leukemias [8] | LIANG-IN LIN ; Lin T.-C.; WEN-CHIEN CHOU ; JIH-LUH TANG ; Lin D.-T.; HWEI-FANG TIEN | Leukemia | 46 | 43 | |
2006 | Nucleophosmin mutations in de novo acute myeloid leukemia: The age-dependent incidences and the stability during disease evolution | WEN-CHIEN CHOU ; JIH-LUH TANG ; LIANG-IN LIN ; MING YAO ; WOEI TSAY ; Chen, Chien-Yuan ; SHANG-JU WU ; Huang C.-F.; Chiou R.-J.; Tseng M.-H.; Lin D.-T.; Lin K.-H.; YAO-CHANG CHEN ; HWEI-FANG TIEN | Cancer Research | 150 | 139 | |
2022 | Oncogenesis induced by combined Phf6 and Idh2 mutations through increased oncometabolites and impaired DNA repair | Chen, Tsung-Chih; CHI-YUAN YAO ; Chen, Yu-Ren; CHANG-TSU YUAN ; CHIEN-CHIN LIN ; Hsu, Yueh-Chwen; Chuang, Po-Han; Kao, Chein-Jun; Li, Yi-Hung; HSIN-AN HOU ; WEN-CHIEN CHOU ; HWEI-FANG TIEN | Oncogene | 2 | 2 | |
2022 | PD-L1 expression in megakaryocytes and its clinicopathological features in primary myelofibrosis patients | Lee, Sze-Hwei; CHIEN-CHIN LIN ; Wei, Chao-Hong; Chang, Ko-Ping; CHANG-TSU YUAN ; CHENG-HONG TSAI ; Liu, Jia-Hao; HSIN-AN HOU ; Tang, Jih-Lu; WEN-CHIEN CHOU ; HWEI-FANG TIEN | The journal of pathology. Clinical research | 1 | 1 | |
2012 | Persistence of mutant isocitrate dehydrogenase in patients with acute myeloid leukemia in remission | WEN-CHIEN CHOU ; Peng K.-Y.; Lei W.-C.; BOR-SHENG KO ; WOEI TSAY ; CHING-HUA KUO ; HWEI-FANG TIEN | Leukemia | 20 | 19 | |
2022 | Phase 3 trial of gilteritinib plus azacitidine vs azacitidine for newly diagnosed FLT3mut+ AML ineligible for intensive chemotherapy | Wang, Eunice S; Montesinos, Pau; Minden, Mark D; Lee, Je-Hwan; Heuser, Michael; Naoe, Tomoki; WEN-CHIEN CHOU ; Laribi, Kamel; Esteve, Jordi; Altman, Jessica K; Havelange, Violaine; Watson, Anne-Marie; Gambacorti-Passerini, Carlo; Patkowska, Elzbieta; Liu, Shufang; Wu, Ruishan; Philipose, Nisha; Hill, Jason E; Gill, Stanley C; Rich, Elizabeth Shima; Tiu, Ramon V | Blood | 51 | 35 | |
2019 | Phf6-null hematopoietic stem cells have enhanced self-renewal capacity and oncogenic potentials | Hsu Y.-C.; Chen T.-C.; CHIEN-CHIN LIN ; CHANG-TSU YUAN ; CHIA-LANG HSU ; HSIN-AN HOU ; Kao C.-J.; Chuang P.-H.; Chen Y.-R.; WEN-CHIEN CHOU ; HWEI-FANG TIEN | Blood Advances | 23 | 20 | |
2022 | Polatuzumab vedotin-based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience | Wang, Yu-Wen; Tsai, Cheng-Hong ; HSIN-AN HOU ; FENG-MING TIEN ; JIA-HAU LIU ; WEN-CHIEN CHOU ; BOR-SHENG KO ; Chen, Yu-Wen; CHIEN-CHIN LIN ; Chieh-Lung Cheng ; Lo, Min-Yen; YUN-CHU LIN ; LI-CHUN LU ; SHANG-JU WU ; SUNG-HSIN KUO ; RUEY-LONG HONG ; TAI-CHUNG HUANG ; MING YAO | Annals of hematology | 10 | 9 | |
2023 | Poor prognostic implications of myelodysplasia-related mutations in both older and younger patients with de novo AML | CHENG-HONG TSAI ; Sun, Kuo-Jui; Lo, Min-Yen; FENG-MING TIEN ; YUAN-YEH KUO ; Tseng, Mei-Hsuan; Peng, Yen-Ling; Chuang, Yi-Kuang; BOR-SHENG KO ; JIH-LUH TANG ; Sun, Hsun-I; Liu, Ming-Chih; CHIA-WEN LIU ; CHIEN-CHIN LIN ; MING YAO ; WEN-CHIEN CHOU ; HSIN-AN HOU ; HWEI-FANG TIEN | Blood cancer journal | 5 | 3 | |
2011 | The prognostic impact and stability of Isocitrate dehydrogenase 2 mutation in adult patients with acute myeloid leukemia | WEN-CHIEN CHOU ; Lei W.-C.; BOR-SHENG KO ; HSIN-AN HOU ; Chen C.-Y.; JIH-LUH TANG ; MING YAO ; WOEI TSAY ; SHANG-JU WU ; SHANG-YI HUANG ; SZU-CHUN HSU ; YAO-CHANG CHEN ; Chang Y.-C.; KUAN-TING KUO ; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tseng M.-H.; Huang C.-F.; HWEI-FANG TIEN | Leukemia | 132 | 132 | |